共 50 条
- [31] Catalytic chelators: Mechanism and implications for drug design. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U212 - U212
- [33] Shape signatures and receptor based drug design. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U528 - U529
- [34] Protein family clustering as an aid to drug design. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U425 - U425
- [35] Discovery of risedronate: An interdisciplinary approach in drug design. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U34 - U34
- [36] Catalytic chelators: Mechanism and implications for drug design. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U833 - U833
- [38] Atomic index of charge and orbital controlled intermolecular interaction in molecular modeling for QSAR in drug design. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U594 - U594
- [39] PHASE TRANSITIONAL BEHAVIOR AND CHARGE DENSITY STUDY OF DRUG METHIMAZOLE ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2019, 75 : E367 - E367
- [40] A mathematical programming approach to DHFR inhibitor drug design. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U696 - U696